Gut peptides, including glucagon-like peptide-1 (GLP-1), regulate metabolic homeostasis and have emerged as the basis for multiple state-of-the-art diabetes and obesity therapies. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.